Myelin Pathology in Progressive Supranuclear Palsy

Overview

flowchart TD
    MYELIN["MYELIN"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
    MYELIN["MYELIN"] -->|"activates"| Inflammation["Inflammation"]
    MYELIN["MYELIN"] -->|"activates"| Als["Als"]
    MYELIN["MYELIN"] -->|"activates"| MICROGLIA["MICROGLIA"]
    MYELIN["MYELIN"] -->|"activates"| ASTROCYTE["ASTROCYTE"]
    MYELIN["MYELIN"] -->|"activates"| Alzheimer["Alzheimer"]
    MYELIN["MYELIN"] -->|"associated with"| Als["Als"]
    MYELIN["MYELIN"] -->|"therapeutic target"| Multiple_Sclerosis["Multiple Sclerosis"]
    MYELIN["MYELIN"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    MYELIN["MYELIN"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    MYELIN["MYELIN"] -->|"activates"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
    MYELIN["MYELIN"] -->|"associated with"| Multiple_Sclerosis["Multiple Sclerosis"]
    MYELIN["MYELIN"] -->|"activates"| Tumor["Tumor"]
    MYELIN["MYELIN"] -->|"activates"| Neuroinflammation["Neuroinflammation"]
    style myelin fill:#4fc3f7,stroke:#333,color:#000

Myelin Pathology in Progressive Supranuclear Palsy represents a critical yet underappreciated component of PSP neuropathology. While PSP is classically characterized by tau-loaded neurons and glia, substantial white matter degeneration contributes to clinical manifestation, particularly gait impairment, axial rigidity, and pseudobulbar symptoms. This page synthesizes current understanding of myelin breakdown in PSP, its relationship to oligodendroglial tau pathology, comparison with other 4R tauopathies, and therapeutic implications.

Molecular Mechanisms of Myelin Breakdown in PSP

Primary Tau-Mediated Myelin Injury

In PSP, 4R tau pathology directly targets oligodendrocytes, the cells responsible for producing and maintaining the myelin sheath. Unlike Alzheimer’s disease where myelin breakdown is largely secondary to neuronal loss, PSP demonstrates primary oligodendroglial involvement that precedes significant axonal degeneration in many cases^{1Neuropathology of PSP (2020)2020 · DOI 10.1007/s00401-020-02149-3Open reference}. The mechanisms include:

1. Oligodendrocyte Tau Accumulation: PSP-specific tau strains accumulate in oligodendrocytes, forming coiled bodies and oligodendroglial tau inclusions that disrupt normal cellular function. This tau burden impairs oligodendrocyte metabolic support to axons^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}.

2. Myelin Basic Protein (MBP) Dysregulation: Post-mortem studies demonstrate reduced MBP expression in PSP white matter, correlating with the severity of oligodendroglial tau pathology. MBP is essential for myelin compaction and structural integrity^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}.

3. Activation of Proteolytic Pathways: Calpain and caspase activation in PSP white matter leads to proteolytic cleavage of myelin proteins, including MBP and proteolipid protein (PLP). This proteolysis precedes visible demyelination on histological examination^{4Calpain activation in PSP white matter (2020)2020 · DOI 10.1016/j.neurobiolaging.2020.03.015Open reference}.

Secondary Mechanisms

Beyond direct tau-mediated injury, secondary mechanisms amplify myelin loss:

Iron-Mediated Oxidative Damage: Elevated iron accumulation in PSP globus pallidus and Subthalamic nucleus extends to white matter tracts. Iron catalyzes hydroxyl radical formation through Fenton chemistry, causing lipid peroxidation of myelin membranes—rich in cholesterol and sphingolipids^{5Iron accumulation in PSP (1991)1991 · DOI 10.1001/archneur.1991.00530190065016Open reference}.

Neuroinflammation-Driven Demyelination: Activated microglia in PSP white matter produce pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) that inhibit oligodendrocyte precursor differentiation and promote myelin breakdown. TSPO-PET studies demonstrate widespread microglial activation in PSP white matter beyond classical subcortical nuclei^{6TSPO-PET in PSP (2016)2016 · DOI 10.1093/brain/awv407Open reference}.

Axonal Degeneration Feedback Loop: Tau-mediated axonal transport impairment in PSP leads to reduced neurotrophic support to oligodendrocytes. Axonal degeneration then triggers secondary myelin breakdown, creating a feed-forward destructive cascade^{7Axon-oligodendrocyte interactions (2019)2019 · DOI 10.1007/s00401-019-02026-0Open reference}.

Regional Pattern of White Matter Involvement

Most Affected Regions

Corticospinal Tract: Demyelination of corticospinal fibers contributes to spasticity and hyperreflexia in PSP. The degeneration is most prominent in the precentral gyrus white matter and internal capsule^{8Corticospinal tract degeneration in PSP (2005)2005 · DOI 10.1002/mds.20488Open reference}.

Corpus Callosum: Interhemispheric connectivity disruption via callosal demyelination underlies the frontal lobe syndrome and axial rigidity in PSP. Advanced PSP cases show 40-60% reduction in corpus callosal thickness^{9Corpus callosum atrophy in PSP (2008)2008 · DOI 10.1002/mds.22277Open reference}.

Brainstem White Matter: The pontine crossing fibers and tegmental tracts show prominent myelin loss, contributing to gait impairment, postural instability, and ocular motor deficits. This correlates with the characteristic “hummingbird” sign on mid-sagittal MRI^{10Brainstem white matter in PSP (2007)2007 · DOI 10.1007/s00401-007-0213-xOpen reference}.

Internal Capsule and Basal Ganglia White Matter: White matter in the region of the globus pallidus and internal capsule shows early involvement, reflecting the selective vulnerability of basal ganglia circuits^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}0.

Regional Vulnerability Gradient

The pattern of white matter involvement in PSP follows a characteristic gradient:

1. Basal ganglia white matter (greatest vulnerability)

2. Brainstem corticospinal tracts

3. Corpus callosum

4. Periventricular white matter

5. Cortical U-fibers (relatively spared until advanced stages)

This gradient mirrors the distribution of 4R tau pathology in oligodendrocytes and explains the prominent subcortical clinical features of PSP^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}1.

Comparison with Other Tauopathies

PSP vs. Corticobasal Syndrome (CBS)

Both PSP and CBS are 4R tauopathies, but myelin pathology differs:

CBS shows more asymmetric white matter involvement reflecting the hemiparetic clinical presentation, while PSP demonstrates symmetric brainstem-predominant demyelination^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}2.

PSP vs. Alzheimer’s Disease

The myelin pathology profiles differ substantially:

• AD: Myelin breakdown is secondary to synaptic and neuronal loss, with tau pathology primarily neuronal

• PSP: Primary oligodendroglial tau pathology causes early, independent myelin degeneration

• AD shows temporoparietal white matter predomination; PSP shows subcortical/brainstem predomination^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}3

PSP vs. Multiple System Atrophy (MSA)

MSA and PSP both involve oligodendrocytes, but with different pathological proteins:

Despite both being “oligodendrogliopathies,” the myelin breakdown patterns differ due to distinct protein aggregates and regional vulnerabilities^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}4.

MRI and Imaging Biomarkers

Conventional MRI Findings

• T2/FLAIR hyperintensities: Subcortical white matter hyperintensities in PSP, particularly in the frontal lobes and brainstem

• Atrophy patterns: Callosal atrophy (midbody thinning), pontine atrophy, and selective midbrain atrophy

• “Hummingbird” sign: Visualized on mid-sagittal T1 as atrophy of the midbrain relative to pons^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}5

Advanced Imaging Markers

Diffusion Tensor Imaging (DTI) reveals:

• Reduced fractional anisotropy (FA) in corpus callosum, internal capsule, and corticospinal tracts

• Elevated mean diffusivity (MD) in PSP white matter correlates with clinical severity^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}6

Magnetic Resonance Spectroscopy (MRS):

• Reduced N-acetylaspartate (NAA) in white matter indicates axonal loss

• Elevated choline reflects demyelination^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}7

PET Imaging:

• Reduced [11C]PIB binding in white matter suggests minimal amyloid co-pathology in classic PSP

• TSPO-PET shows microglial activation correlating with white matter inflammation^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}8

Clinical Correlations

Gait and Balance

White matter degeneration in the brainstem and basal ganglia contributes significantly to the postural instability and falls that characterize PSP. Damage to reticulospinal tracts impairs postural reflexes, while corticospinal tract involvement contributes to axial rigidity^{2Oligodendroglial tau in PSP (1998)1998 · DOI 10.1001/archneur.55.4.560Open reference}9.

Oculomotor Deficits

Demyelination of the pretectal region and ocular motor nuclei contributes to vertical supranuclear gaze palsy. The characteristic downgaze deficit correlates with white matter changes in the pretectal area^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}0.

Cognitive Impairment

Frontal white matter disconnection—via corpus callosal demyelination—underlies the frontal lobe syndrome in PSP. Executive dysfunction correlates with DTI measures of frontal white matter integrity^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}1.

Pseudobulbar Affect

White matter involvement in the pontine tegmentum and corticobulbar tracts contributes to dysarthria and pseudobulbar affect, common in PSP^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}2.

Therapeutic Implications

Current Approaches

Tau-Targeted Therapies:

• ASO therapies (BIIB080, IONIS-MAPTRx) may reduce oligodendroglial tau production

• Anti-tau antibodies (gosuranemab, tilavonemab) failed in PSP—potentially due to insufficient white matter penetration^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}3

Myelin Protection Strategies:

• Clemastine and benztropine promote remyelination in preclinical models

• No clinical trials specifically targeting remyelination in PSP^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}4

Emerging Strategies

Lipid-Based Therapeutics: Myelin is rich in cholesterol and galactosylceramides. Approaches to stabilize myelin lipids show promise in preclinical models^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}5.

Oligodendrocyte Precursor Cell (OPC) Stimulation: PDGFRα agonists promote OPC differentiation into mature oligodendrocytes. This approach could potentially reverse myelin loss in PSP^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}6.

Iron Chelation: Deferoxamine and deferasirox may reduce iron-mediated myelin oxidative damage, though clinical trials in PSP have been limited^{3Myelin proteins in tauopathies (2013)2013 · DOI 10.1007/s00401-013-1109-0Open reference}7.

Research Gaps and Future Directions

1. Longitudinal White Matter Imaging: No large-scale longitudinal DTI studies in PSP to characterize myelin loss progression

2. Oligodendrocyte-Specific Biomarkers: Need biomarkers targeting oligodendrocyte health (e.g., myelin vesicles, specific microRNAs)

3. Human Post-Mortem Studies: Detailed oligodendrocyte molecular profiling in PSP is limited

4. Therapeutic Penetration: Blood-brain barrier and white matter penetration remains a challenge for most candidate therapeutics

See Also

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• PubMed

• KEGG Pathways